000 01407 a2200421 4500
005 20250511192102.0
264 0 _c19920429
008 199204s 0 0 eng d
022 _a0344-5704
024 7 _a10.1007/BF00686006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEccles, D M
245 0 0 _aA phase I and pharmacology study of GR63178A, a water-soluble analogue of mitoquidone.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_c1992
300 _a375-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Evaluation
650 0 4 _aHumans
650 0 4 _aIsoquinolines
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aOrganophosphorus Compounds
_xadministration & dosage
650 0 4 _aSolubility
650 0 4 _aTime Factors
700 1 _aCummings, J
700 1 _aStewart, M E
700 1 _aNicolson, M
700 1 _aCornbleet, M A
700 1 _aLeonard, R C
700 1 _aSmyth, J F
773 0 _tCancer chemotherapy and pharmacology
_gvol. 29
_gno. 5
_gp. 375-8
856 4 0 _uhttps://doi.org/10.1007/BF00686006
_zAvailable from publisher's website
999 _c1557659
_d1557659